Does Pitavastatin Magnesium Interact with Cyclosporine?
CDI records a contraindicated classification for Pitavastatin Magnesium and Cyclosporine. The stored summary is: Cyclosporine significantly increases pitavastatin exposure and increases the risk of myopathy and rhabdomyolysis. Concomitant use is contraindicated. The mechanism involves increased pitavastatin exposure. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Contraindicated
- Pitavastatin Magnesium Class
- HMG-CoA Reductase Inhibitor
- Cyclosporine Class
- Calcineurin Inhibitor Immunosuppressant
- Management
- Do not take together
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Increased pitavastatin exposure
What To Tell Your Doctor or Pharmacist
If you are taking Pitavastatin Magnesium and your doctor is considering prescribing Cyclosporine (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask about alternative medications that do not interact with your current regimen
- Ask how frequently you should be monitored while these are co-prescribed
- Never stop or change either medication without first consulting your healthcare provider